These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. [The role of biologic therapy in the treatment of extraintestinal manifestations and complications of inflammatory bowel disease]. Kujundzić M Acta Med Croatica; 2013 Apr; 67(2):195-201. PubMed ID: 24471303 [TBL] [Abstract][Full Text] [Related]
3. The prevalence of extraintestinal diseases in inflammatory bowel disease: a population-based study. Bernstein CN; Blanchard JF; Rawsthorne P; Yu N Am J Gastroenterol; 2001 Apr; 96(4):1116-22. PubMed ID: 11316157 [TBL] [Abstract][Full Text] [Related]
6. [Extraintestinal complications in patients with ulcerative colitis]. Oshitani N; Watanabe K; Nakamura S; Higuchi K; Arakawa T Nihon Rinsho; 2005 May; 63(5):874-8. PubMed ID: 15881184 [TBL] [Abstract][Full Text] [Related]
7. Chronological Order of Appearance of Extraintestinal Manifestations Relative to the Time of IBD Diagnosis in the Swiss Inflammatory Bowel Disease Cohort. Vavricka SR; Rogler G; Gantenbein C; Spoerri M; Prinz Vavricka M; Navarini AA; French LE; Safroneeva E; Fournier N; Straumann A; Froehlich F; Fried M; Michetti P; Seibold F; Lakatos PL; Peyrin-Biroulet L; Schoepfer AM Inflamm Bowel Dis; 2015 Aug; 21(8):1794-800. PubMed ID: 26020601 [TBL] [Abstract][Full Text] [Related]
8. Efficacy of adalimumab for the treatment of extraintestinal manifestations of Crohn's disease. Barreiro-de-Acosta M; Lorenzo A; Domínguez-Muñoz JE Rev Esp Enferm Dig; 2012 Sep; 104(9):468-72. PubMed ID: 23130854 [TBL] [Abstract][Full Text] [Related]
9. [Extraintestinal manifestations in Crohn's disease: risk factors and influence of intestinal surgery]. Nascimbeni R; Di Fabio F; Lanzini A; Lanzarotto F; Ricci C; Casella C; Salerni B Ann Ital Chir; 2009; 80(4):293-8. PubMed ID: 19967888 [TBL] [Abstract][Full Text] [Related]
10. Predictive factors for erythema nodosum and pyoderma gangrenosum in inflammatory bowel disease. Ampuero J; Rojas-Feria M; Castro-Fernández M; Cano C; Romero-Gómez M J Gastroenterol Hepatol; 2014 Feb; 29(2):291-5. PubMed ID: 23927379 [TBL] [Abstract][Full Text] [Related]
11. Erythema nodosum and pyoderma gangrenosum in 50 patients with Crohn's disease. Freeman HJ Can J Gastroenterol; 2005 Oct; 19(10):603-6. PubMed ID: 16247522 [TBL] [Abstract][Full Text] [Related]
12. Occurrence of skin manifestations in patients of the Swiss Inflammatory Bowel Disease Cohort Study. Roth N; Biedermann L; Fournier N; Butter M; Vavricka SR; Navarini AA; Rogler G; Scharl M; PLoS One; 2019; 14(1):e0210436. PubMed ID: 30682031 [TBL] [Abstract][Full Text] [Related]
15. TRAF3IP2 gene is associated with cutaneous extraintestinal manifestations in inflammatory bowel disease. Ciccacci C; Biancone L; Di Fusco D; Ranieri M; Condino G; Giardina E; Onali S; Lepre T; Pallone F; Novelli G; Borgiani P J Crohns Colitis; 2013 Feb; 7(1):44-52. PubMed ID: 22445837 [TBL] [Abstract][Full Text] [Related]
16. Relationship between clinical features of Crohn's disease and the risk of developing extraintestinal manifestations. Barreiro-de Acosta M; Domínguez-Muñoz JE; Núñez-Pardo de Vera MC; Lozano-León A; Lorenzo A; Peña S Eur J Gastroenterol Hepatol; 2007 Jan; 19(1):73-8. PubMed ID: 17206080 [TBL] [Abstract][Full Text] [Related]
17. Characterization and prevalence of extraintestinal manifestations in a cohort of patients with inflammatory intestinal disease in Medellin, Colombia. Juliao-Baños F; Arrubla M; Osorio L; Camargo J; Londoño J; Cáceres C; Carvajal J; Mosquera-Klinger G; Donado J Gastroenterol Hepatol; 2021; 44(6):398-404. PubMed ID: 33172691 [TBL] [Abstract][Full Text] [Related]
18. Osteoporosis and other extraintestinal symptoms and complications of inflammatory bowel diseases. Reinshagen M; von Tirpitz C Dig Dis; 2003; 21(2):138-45. PubMed ID: 14571111 [No Abstract] [Full Text] [Related]